The biology and clinical impact of genetic lesions in myeloid malignancies.
about
Guidelines for the management of myeloproliferative neoplasmsMolecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.The complexity of interpreting genomic data in patients with acute myeloid leukemia.Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.Advances in treating acute myeloid leukemia.Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.The serum tryptase test: an emerging robust biomarker in clinical hematology.The genetic basis of myelodysplasia and its clinical relevanceKRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.Understanding leukemic hematopoiesis as a complex adaptive system.From helix to hematology: introduction to a collection of reviews on the emerging role of next-generation sequencing in hematology.Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Acute myeloid leukaemia.Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.Clinical course of patients with incidental finding of 20q- in the bone marrow without a morphologic evidence of myeloid neoplasm.High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).
P2860
Q26778326-42AC6B85-EA66-4ED7-A727-DA86763B2A24Q26801573-BE01140A-D985-4DD1-9B70-5AB7F2351460Q30252566-C5E5DCB8-6737-48FD-9FD7-3DC867EE2719Q30397539-FA8B2804-122E-476D-A433-EEE93DA421F8Q31149503-5AA574FF-F312-4122-9B0C-8DA3B649657BQ34227741-9D5902BE-9FAA-40CB-B16D-621873F2E7DFQ34312351-7A70A66E-CDD7-4468-9C8E-EDA81632AD17Q36054758-2CE76E49-0110-4189-8DBC-5F90C3DCC70BQ36154674-1C2FFF9F-C865-4BB3-BF09-BA24DFFA70D7Q37390236-301E27A4-566B-4EE8-B0D5-C4E08A249E6BQ38715792-39DED0EE-2755-43EF-B028-53684654E963Q39942266-754FA9BC-6D83-4464-9EC3-0A13E46BAC4FQ42878867-1770A3E7-A267-4289-ACF8-F9B71DA8B449Q42916400-4300218A-5BAA-42D2-A4A9-7660C49B03B1Q47135060-B063C00D-FFF1-415B-A364-AEDA2184036DQ47432401-0978F800-5197-472A-902F-0887255E9224Q48102067-139E0F75-E4ED-4CF0-AF93-5F35D8B7236CQ52882588-2A11A0BD-EADC-4C3D-80A5-98DF5749DC16Q53518700-5557DE51-F0B1-41FB-A320-494748E8D358
P2860
The biology and clinical impact of genetic lesions in myeloid malignancies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The biology and clinical impact of genetic lesions in myeloid malignancies.
@en
type
label
The biology and clinical impact of genetic lesions in myeloid malignancies.
@en
prefLabel
The biology and clinical impact of genetic lesions in myeloid malignancies.
@en
P1433
P1476
The biology and clinical impact of genetic lesions in myeloid malignancies
@en
P2093
Benjamin L Ebert
P304
P356
10.1182/BLOOD-2013-06-460295
P407
P577
2013-08-16T00:00:00Z